These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 34576078)

  • 1. The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
    Brandi G; Turroni S; McAllister F; Frega G
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
    Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota: Its Potential Roles in Pancreatic Cancer.
    Li Q; Jin M; Liu Y; Jin L
    Front Cell Infect Microbiol; 2020; 10():572492. PubMed ID: 33117731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microbiota and microbiome in pancreatic cancer: more influential than expected.
    Wei MY; Shi S; Liang C; Meng QC; Hua J; Zhang YY; Liu J; Zhang B; Xu J; Yu XJ
    Mol Cancer; 2019 May; 18(1):97. PubMed ID: 31109338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The correlation between gut and intra-tumor microbiota and PDAC: Etiology, diagnostics and therapeutics.
    Qian J; Zhang X; Wei B; Tang Z; Zhang B
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188943. PubMed ID: 37355177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiome and Pancreatic Cancer Development and Treatment.
    Attebury H; Daley D
    Cancer J; 2023 Mar-Apr 01; 29(2):49-56. PubMed ID: 36957973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host Microbiomes in Tumor Precision Medicine: How far are we?
    D'Amico F; Barone M; Tavella T; Rampelli S; Brigidi P; Turroni S
    Curr Med Chem; 2022; 29(18):3202-3230. PubMed ID: 34986765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of gut microbiome as a non-invasive predictive biomarker for early detection of pancreatic cancer and hepatocellular carcinoma.
    Kaźmierczak-Siedlecka K; Stachowska E; Folwarski M; Przewłócka K; Makarewicz W; Bryl E
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7275-7284. PubMed ID: 34919227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering Strategies to Modulate the Gut Microbiome and Immune System.
    Han K; Xu J; Xie F; Crowther J; Moon JJ
    J Immunol; 2024 Jan; 212(2):208-215. PubMed ID: 38166246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.
    Chu CS; Yang CY; Yeh CC; Lin RT; Chen CC; Bai LY; Hung MC; Lin CC; Wu CY; Lin JT
    Sci Rep; 2022 Jan; 12(1):107. PubMed ID: 34997106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The microbiome and hepatobiliary-pancreatic cancers.
    Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
    Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.
    Riquelme E; Zhang Y; Zhang L; Montiel M; Zoltan M; Dong W; Quesada P; Sahin I; Chandra V; San Lucas A; Scheet P; Xu H; Hanash SM; Feng L; Burks JK; Do KA; Peterson CB; Nejman D; Tzeng CD; Kim MP; Sears CL; Ajami N; Petrosino J; Wood LD; Maitra A; Straussman R; Katz M; White JR; Jenq R; Wargo J; McAllister F
    Cell; 2019 Aug; 178(4):795-806.e12. PubMed ID: 31398337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out.
    Conti G; D'Amico F; Fabbrini M; Brigidi P; Barone M; Turroni S
    Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the microbiome in pancreatic oncogenesis.
    Daley D
    Int Immunol; 2022 Sep; 34(9):447-454. PubMed ID: 35863313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body site-dependent variations of microbiota in pancreatic cancer pathophysiology.
    Panebianco C; Pazienza V
    Crit Rev Clin Lab Sci; 2019 Jun; 56(4):260-273. PubMed ID: 31060399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
    Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
    World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
    Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
    Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotics intervention in colorectal cancer: From traditional approaches to novel strategies.
    Ha S; Zhang X; Yu J
    Chin Med J (Engl); 2024 Jan; 137(1):8-20. PubMed ID: 38031348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.